To further confirm the role of Six1 in enhancing the stemness of breast cancer cells, we injected different amounts of 66cl4-SCR-luc, 66cl4-shSix1 KD1-luc, and 66cl4-shSix1 KD2-luc cells to assess their tumorigenic ability. Here, SIX1 is linked to breast cancer.